Apthera's Acquisition

Apthera was acquired by RXi Pharmaceuticals on April 19, 2011.

Apthera is a privately-held biotechnology company developing a pipeline of peptide based immune-therapies. In April 2011, Apthera was acquired by RXi Pharmaceuticals. The valuation of Apthera was $7.…

Articles about Apthera's Acquisition: